Erythropoietin Improves the Accumulation and Therapeutic Effects of Carboplatin by Enhancing Tumor Vascularization and Perfusion

Recombinant human erythropoietin (rhuEpo) is currently under debate for the treatment of chemotherapy-induced anemia due to clinical trials showing adverse effects in Epo-treated patients and the discovery of the erythropoietin-receptor (EpoR) in tumor and endothelial cells. Here, using Epo-Cy5.5 as...

Descripción completa

Detalles Bibliográficos
Autores principales: Doleschel, Dennis, Rix, Anne, Arns, Susanne, Palmowski, Karin, Gremse, Felix, Merkle, Ruth, Salopiata, Florian, Klingmüller, Ursula, Jarsch, Michael, Kiessling, Fabian, Lederle, Wiltrud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440446/
https://www.ncbi.nlm.nih.gov/pubmed/26000061
http://dx.doi.org/10.7150/thno.11304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440446/
https://www.ncbi.nlm.nih.gov/pubmed/26000061
http://dx.doi.org/10.7150/thno.11304

Ejemplares similares